Health
GSK, Pfizer Must Face Zantac Cases in Delaware, Judge Rules
- About 75,000 suits filed in state after federal cases tossed
- Decision comes on heels of woman’s loss in first Zantac trial
This article is for subscribers only.
GSK Plc, Pfizer Inc. and other drugmakers must face trials in state court in Delaware after a judge found the evidence backing up claims the companies’ former Zantac heartburn treatment causes cancer is legitimate and can be heard by juries.
Superior Court Judge Vivian Medinilla concluded late Friday that consumers aren’t relying on flawed science to support allegations Zantac — owned by different companies at different times – caused a variety of cancers. She also found disputes over experts’ analyses of those health risks can be properly debated at trial. About 75,000 consumers have filed suit in Delaware targeting former makers of the treatment.